Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.01468-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Bin Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Key Laboratory of Oncology (2024SSY06041), JXHC Key Laboratory of Tumour Metastasis, NHC Key Laboratory of Personalized Diagnosis and Treatme…. Hauptthemen laut MEDLINE: Neoplasms, Drug Resistance, Multiple, Bacterial, Bacteremia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer patients are particularly vulnerable to bloodstream infections (BSIs) due to their immunocompromised status. This retrospective study at Jiangxi Cancer Hospital (2019 to 2024) analyzed the bacterial spectrum, risk factors, and antimicrobial susceptibility profiles of BSIs in cancer patients. Logistic regression analysis was performed to identify risk factors associated with multidrug resistance (MDR) in Gram-positive and Gram-negative infections. A total of 1,161 bacteria were isolated from 954 oncological patients in 1,095 BSI episodes. Among these, 62.79% were Gram-negative bacteria, with Escherichia coli (40.88%) and Klebsiella pneumoniae (19.07%) being the most prevalent. Gram-positive bacteria accounted for 37.21% of isolates, with Staphylococcus aureus (26.16%) being the most common. Gram-negative infections were more prevalent in patients with breast, gastrointestinal, hepatobiliary, and pancreatic cancers, whereas Gram-positive infections were more common among those with lymphoma, head and neck, and lung cancers, as well as in patients undergoing invasive procedures. High resistance rates were observed against ampicillin, piperacillin, cefazolin, and erythromycin, whereas tigecycline and nitrofurantoin exhibited low resistance rates among the tested bacterial isolates. Among Gram-negative bacteria, 5.48% were carbapenemase producers and 15.36% were extended-spectrum β-lactamase (ESBL) producers. Moreover, methicillin resistance was observed in 36.04% of Staphylococcus aureus and 66.83% of coagulase-negative Staphylococcus isolates. MDR was observed in 40.19% of Gram-negative and 50.92% of Gram-positive infections. Hypoproteinemia (OR 3.2) was identified as an independent risk factor for MDR-BSIs caused by Gram-negative bacteria. The high prevalence of MDR bacteria in BSIs among cancer patients highlights the necessity of individualized treatment and continuous monitoring in oncology settings. IMPORTANCE This study addresses a critical gap in understanding the epidemiology and risk factors of multidrug-resistant bloodstream infections (MDR-BSIs) in oncology patients from a high-burden region of China. By analyzing over a thousand BSI episodes over 6 years, the study identifies the predominant bacterial species, their resistance profiles, and key clinical and procedural risk factors associated with MDR. The high rates of MDR among both Gram-negative and Gram-positive pathogens underscore the urgent need for tailored antimicrobial stewardship, infection control interventions, and individualized treatment strategies. These findings provide essential evidence for guiding empirical antibiotic choices and improving infection management protocols in cancer care settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi Key Laboratory of Oncology (2024SSY06041), JXHC Key Laboratory of Tumour Metastasis, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital & Institute, T…
- Department of Medical Laboratory, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, Jiangxi, China.
- Department of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
- Research Institute of Clinical Pharmacy, Department of Pharmacology, Shantou University Medical College, Shantou, China.
- Department of Dermatology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Muhammad Shafiq, Qiao-Li Lv, Hazrat Bilal
Zitieren
APA
Xu, B., Wang, X., Li, X., Khan, M. N., Shafiq, M., Khan, S., Yu, T., Khan, R. U., Song, Y., Qiu, H., Lv, Q. L., & Bilal, H. (2025). Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01468-25
Vancouver
Xu B, Wang X, Li X, Khan MN, Shafiq M, Khan S, et al. Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01468-25
BibTeX
@article{Xu2025,
author = {Xu, Bin and Wang, Xunsong and Li, Xiaohui and Khan, Muhammad Nadeem and Shafiq, Muhammad and Khan, Sabir and Yu, Tenghua and Khan, Rahat Ullah and Song, Ying and Qiu, Hanman and Lv, Qiao-Li and Bilal, Hazrat},
title = {Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.01468-25}
}
EUVIMED